Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats

被引:71
|
作者
Hussein, Osamah
Grosovski, Masha
Lasri, Etti
Svalb, Sergio
Ravid, Uzi
Assy, Nimer
机构
[1] Sieff Govt Hosp, Dept Internal Med A, Liver Unit, IL-13100 Safed, Israel
[2] Sieff Govt Hosp, Liver Unit, Safed, Israel
[3] Sieff Govt Hosp, Dept Pathol, Safed, Israel
[4] Technion Israel Inst Technol, Fac Med, IL-32000 Haifa, Israel
[5] Ort Braude Coll Engn, Karmiel, Israel
[6] Minist Agr, Newe Yaar Res Ctr, Ramat Yeshai, Israel
关键词
fatty liver; non-alcoholic steatohepatitis; dietary fat; fatty acids; methionine choline-deficient diet; insulin resistance; olive oil; oxidative stress; paraoxonase;
D O I
10.3748/wjg.v13.i3.361
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To evaluate the effects of different types of dietary fats on the hepatic lipid content and oxidative stress parameters in rat liver with experimental non-alcoholic fatty liver disease (NAFLD). METHODS: A total of 32 Sprague-Dawley rats were randomly divided into five groups. The rats in the control group (n = 8) were on chow diet (Group 1), rats (n = 6) on methionine choline-deficient diet (MCDD) (Group 2), rats (n = 6) on MCDD enriched with olive oil (Group 3), rats (n 6) on MCDD with fish oil (Group 4) and rats (n = 6) on MCDD with butter fat (Group 5). After 2 mo, blood and liver sections were examined for lipids composition and oxidative stress parameters. RESULTS: The liver weight/rat weight ratio increased in all treatment groups as compared with the control group. Severe fatty liver was seen in MCDD + fish oil and in MCDD + butter fat groups, but not in MCDD and MCDD + olive oil groups. The increase in hepatic triglycerides (TG) levels was blunted by 30% in MCDD + olive oil group (0.59 +/- 0.09) compared with MCDD group (0.85 +/- 0.04, P < 0.004), by 37% compared with MCDD + fish oil group (0.95 +/- 0.07, P < 0.001), and by 33% compared with MCDD + butter group (0.09 +/- 0.1, P < 0.01). The increase in serum TG was lowered by 10% in MCDD + olive oil group (0.9 +/- 0.07) compared with MCDD group (1.05 +/- 0.06). Hepatic cholesterol increased by 15-fold in MCDD group [(0.08 +/- 0.02, this increment was blunted by 21% in MCDD + fish oil group (0.09 0.02)]. In comparison with the control group, ratio of long-chain polyunsaturated fatty acids omega-6/omega-3 increased in MCDD + olive oil, MCDD + fish oil and MCDD + butter fat groups by 345-, 30- and 397-fold, respectively. In comparison to MCDD group (1.58 +/- 0.08), hepatic MDA contents in MCDD + olive oil (3.3 +/- 0.6), MCDD + fish oil (3.0 +/- 0.4), and MCDD + butter group (2.9 +/- 0.36) were increased by 108%, 91% and 87%, respectively (P < 0.004). Hepatic paraoxonase activity decreased significantly in all treatment groups, mostly with MCDD + olive oil group (-68%). CONCLUSION: Olive oil decreases the accumulation of triglycericle in the liver of rats with NAFLD, but does not provide the greatest antioxiclant activity. (c) 2007 The WJG Press. All rights reserved.
引用
收藏
页码:361 / 368
页数:8
相关论文
共 50 条
  • [1] Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats
    Osamah Hussein
    Masha Grosovski
    Etti Lasri
    Sergio Svalb
    Uzi Ravid
    Nimer Assy
    [J]. World Journal of Gastroenterology, 2007, (03) : 361 - 368
  • [2] Hepatic lipid metabolism and non-alcoholic fatty liver disease
    Tessari, P.
    Coracina, A.
    Cosma, A.
    Tiengo, A.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (04) : 291 - 302
  • [3] Bone marrow fat content is correlated with hepatic fat content in paediatric non-alcoholic fatty liver disease
    Yu, N. Y.
    Wolfson, T.
    Middleton, M. S.
    Hamilton, G.
    Gamst, A.
    Angeles, J. E.
    Schwimmer, J. B.
    Sirlin, C. B.
    [J]. CLINICAL RADIOLOGY, 2017, 72 (05) : 425.e9 - 425.e14
  • [4] Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging
    Gong, Zhenwei
    Tas, Emir
    Yakar, Shoshana
    Muzumdar, Radhika
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2017, 455 (0C) : 115 - 130
  • [5] Editorial: Paradox of liver fat content in the spectrum of non-alcoholic fatty liver disease
    Chung, Sung Won
    Choi, Jonggi
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (04) : 569 - 570
  • [6] Response to: liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease
    Stender, Stefan
    Tybjaerg-Hansen, Anne
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 (36) : 3399 - 3399
  • [7] Liver fat content, non-alcoholic fatty liver disease, and risk of ischaemic heart disease
    Byrne, Christopher D.
    Targher, Giovanni
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 (36) : 3398 - 3398
  • [8] Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
    Ipsen, David Hojland
    Lykkesfeldt, Jens
    Tveden-Nyborg, Pernille
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2018, 75 (18) : 3313 - 3327
  • [9] Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
    David Højland Ipsen
    Jens Lykkesfeldt
    Pernille Tveden-Nyborg
    [J]. Cellular and Molecular Life Sciences, 2018, 75 : 3313 - 3327
  • [10] Pemafibrate decreases markers of hepatic inflammation in patients with non-alcoholic fatty liver disease
    Shinozaki, Satoshi
    Tahara, Toshiyuki
    Lefor, Alan Kawarai
    Ogura, Masahito
    [J]. CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 6 (03) : 270 - 274